Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland.
Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Cell Death Dis. 2019 Nov 7;10(11):849. doi: 10.1038/s41419-019-2086-z.
Epithelial barriers have to constantly cope with both harmless and harmful stimuli. The epithelial barrier therefore serves as a dynamic and not static wall to safeguard its proper physiological function while ensuring protection. This is achieved through multiple defence mechanisms involving various cell types - epithelial and non-epithelial - that work in an integrated manner to build protective barriers at mucosal sites. Damage may nevertheless occur, due to pathogens, physical insults or dysregulated immune responses, which trigger a physiologic acute or a pathologic chronic inflammatory cascade. Inflammation is often viewed as a pathological condition, particularly due to the increasing prevalence of chronic inflammatory (intestinal) diseases. However, inflammation is also necessary for wound healing. The aetiology of chronic inflammatory diseases is incompletely understood and identification of the underlying mechanisms would reveal additional therapeutic approaches. Resolution is an active host response to end ongoing inflammation but its relevance is under-appreciated. Currently, most therapies aim at dampening inflammation at damaged mucosal sites, yet these approaches do not efficiently shut down the inflammation process nor repair the epithelial barrier. Therefore, future treatment strategies should also promote the resolution phase. Yet, the task of repairing the barrier can be an arduous endeavour considering its multiple integrated layers of defence - which is advantageous for damage prevention but becomes challenging to repair at multiple levels. In this review, using the intestines as a model epithelial organ and barrier paradigm, we describe the consequences of chronic inflammation and highlight the importance of the mucosae to engage resolving processes to restore epithelial barrier integrity and function. We further discuss the contribution of pre-mRNA alternative splicing to barrier integrity and intestinal homeostasis. Following discussions on current open questions and challenges, we propose a model in which resolution of inflammation represents a key mechanism for the restoration of epithelial integrity and function.
上皮屏障必须不断应对无害和有害的刺激。因此,上皮屏障是一种动态的而不是静态的墙壁,它既能保障其正常的生理功能,又能提供保护。这是通过多种防御机制实现的,涉及多种细胞类型——上皮细胞和非上皮细胞——它们以整合的方式在黏膜部位构建保护性屏障。然而,由于病原体、物理损伤或失调的免疫反应,屏障可能会受损,这些因素会引发生理性急性或病理性慢性炎症级联反应。炎症通常被视为一种病理状况,特别是由于慢性炎症(肠道)疾病的发病率不断上升。然而,炎症对于伤口愈合也是必要的。慢性炎症性疾病的病因尚不完全清楚,确定潜在的机制将揭示更多的治疗方法。消退是宿主对持续炎症的主动反应,但它的相关性尚未得到充分认识。目前,大多数治疗方法旨在抑制受损黏膜部位的炎症,但这些方法不能有效地终止炎症过程或修复上皮屏障。因此,未来的治疗策略也应该促进消退阶段。然而,考虑到上皮屏障的多个整合防御层,修复屏障可能是一项艰巨的任务——这对于预防损伤是有利的,但在多个层面上进行修复却具有挑战性。在这篇综述中,我们以肠道作为模型上皮器官和屏障范例,描述了慢性炎症的后果,并强调了黏膜在启动消退过程以恢复上皮屏障完整性和功能方面的重要性。我们进一步讨论了前体 mRNA 可变剪接对屏障完整性和肠道内稳态的贡献。在讨论了当前存在的问题和挑战之后,我们提出了一个模型,其中炎症消退代表了恢复上皮完整性和功能的关键机制。